Laurus Labs Ltd

  • BSE Code : 540222
  • NSE Symbol : LAURUSLABS
  • ISIN : INE947Q01028
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,954.00 5.90(0.30%)

Open Price ()

1,962.00

Prev. Close ()

1,948.10

Volume (No’s)

2,655,873

Market Cap ()

105,577.01

Low Price ()

1,954.00

High Price ()

1,982.00

 

Board Meetings

Start Date End Date Purpose
09-Jul-2026 24-Jul-2026 Quarterly Results Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results For The Quarter Ended June 30, 2026. Financial Results For Quarter Ended 30.06.2026. Change in Directorate (As per BSE announcement dated on : 24.07.2026).
09-Apr-2026 30-Apr-2026 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve the Audited Financial Results For The Quarter And Year Ended March 31 2026 And Payment Of 2Nd Interim Dividend For FY 2025-26. Please see annexed Please see enclosed annexure (As Per BSE Announcement Dated on:30.04.2026)
12-Mar-2026 12-Mar-2026 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Appointment of Statutory Auditors of the Company
09-Jan-2026 23-Jan-2026 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 inter alia to consider and approve the un-audited financial results of the Company for the quarter and nine months ended December 31 2025 Please see enclosed annexure. (As Per BSE Announcement Dated On : 22.01.2026) Please see annexed enclosure (As Per BSE Announcement Dated On : 23.01.2026)
09-Oct-2025 23-Oct-2025 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2025 inter alia to consider and approve The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025 And The Proposal For Payment Of Interim Dividend For FY 2025-26. Outcome of the Board Meeting - October 23, 2025 (As per BSE Announcement dated on: 23.10.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew